A Phase 2 interventional study of Insulin (Humulin) and Placebo in Concussion (Diagnosis) and Mild Traumatic Brain Injury, sponsored by HealthPartners Institute. Recruiting at 1 site in United States. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-13.
Sponsored by HealthPartners Institute · Phase 2, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 419 studies in Brain Concussion with a site in United States — 101 open to participants now, 122 under way, 5 of them phase 3. Brain Concussion · United States.
Among the 419 studies in Brain Concussion with a site in United States, this one is the 118th largest by planned enrollment of the 322 interventional ones that give a count, is one of 24 that started in 2026, is one of 24 in phase 2, reaches primary completion later than 82 of the 121 other live ones, and was the 419th registered.
640 studies on the registry are indexed under Brain Concussion; 166 are open to participants now.
Browse Brain Concussion studies →101 of the 419 studies in Brain Concussion with a site in United States are open now. Recruiting first, the newest first:
Johns Hopkins University · Sites in United States
Ages 18–55
University of Michigan · Sites in United States
Ages 18+
Perception Dynamics Institute · Sites in United States
Ages 18–60
University of Colorado, Denver · Sites in United States
Ages 18+ · Men only
Akiva Cohen · Sites in United States
Ages 11–23 · Healthy volunteers
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 113 Brain Concussion studies recruiting now, 33 (29%) set no upper age limit and 73 (65%) stop at 75 or younger; 24 take children under 18; 38 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
419 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 21 · Phase 2 29 · Phase 3 9 · Phase 4 5
First in 1998; this study’s year is marked. 24 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 96 is above the median of 63 across 448 interventional studies indexed under Brain Concussion.
Median enrollment 60 across the 322 interventional studies, 147 across the 96 observational. Of the 259 that completed or were terminated, 68 (26%) have results posted.
This tab as a report to print or save as PDF → With an account.
59 of 419 have an industry lead sponsor. The 10 most frequent:
HealthPartners Institute is the lead sponsor of 168 studies on the registry; 21 are open to participants now.
Of its 17 completed or terminated interventional studies of FDA-regulated products, 16 (94%) have results posted.
HealthPartners Institute has 4 studies filed under Brain Concussion — fewer than ten, so there is no comparison to draw.
50 of the studies in Brain Concussion with a site in United States that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04867317Phase 3VA Office of Research and DevelopmentGrowth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD) | 2027-02-28 |
| NCT05320822University of North Carolina, Chapel HillA Pragmatic Rehabilitation Intervention: The Active Rehab Study | 2026-11-28 |
| NCT06109909VA Office of Research and DevelopmentPilot Study of Neurofeedback for Photosensitivity in Mild Traumatic Brain Injury | 2026-11-30 |
| NCT02670161Endeavor HealthQuality Improvement and Practice Based Research in Neurology Using the EMR | 2026-12 |
| NCT04708613David Okonkwo, MD, PhDUniversity of Pittsburgh Brain Health Initiative | 2026-12 |
Add all 50 to your calendar (.ics) → With an account.
Among the 419 studies in Brain Concussion with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This Phase II clinical trial protocol will provide evidence as to whether IN insulin is efficacious in reducing symptoms in people seeking care for mild TBI (concussion).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).
Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Childbearing potential
Able to become pregnant: from the first period until menopause, unless permanently unable to through surgery (removal of the womb, or of both ovaries or both fallopian tubes).
Criteria for people of childbearing potential usually ask for a negative pregnancy test and for contraception during the study and for a time after it.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraception
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Clinically significant
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Intranasal insulin, lower dose, 40 IU insulin, twice daily for 21 days
Drug: Insulin (Humulin)
Intranasal insulin, higher dose, 80 IU insulin, twice daily for 21 days
Drug: Insulin (Humulin)
intranasal, twice daily for 21 days
Drug: Placebo
Intranasal regular insulin
Intranasal saline
Change in Post-Concussion Symptom Scale scores (PCSS) from baseline to 21 days
The PCSS is a 22-item self-report inventory of concussion symptoms. Each symptom is rated for severity from 0 (none) to 6 (severe), giving a total score of 0 to 132; higher scores indicate greater symptom burden. Change is calculated as the Day 21 score minus the baseline score, so negative values indicate improvement. Each insulin arm (40 IU and 80 IU) is compared separately with saline, and results are reported as the difference in mean change (insulin minus saline) with a 97.5% confidence interval.
Time frame: baseline and day 21 post-intervention
Differences in time to return to normal activities by day 21
Number of days from intervention to participant-reported return to normal activities. Participants who have not reported a return to normal activities by Day 21 are censored at their last observation. Each insulin arm (40 IU and 80 IU) is compared separately with saline, and results are reported as a hazard ratio (insulin vs. saline) with a 95% confidence interval; a hazard ratio greater than 1 indicates faster return to normal activities with insulin.
Time frame: baseline and day 21 post-intervention
Change in Quality of Life after Brain Injury (QOLIBRI) scores from baseline to 21 days
The QOLIBRI is a 37-item self-report measure of health-related quality of life after traumatic brain injury. The total score ranges from 0 to 100; higher scores indicate better quality of life. Change is calculated as the Day 21 score minus the baseline score, so positive values indicate improvement. Each insulin arm (40 IU and 80 IU) is compared separately with saline, and results are reported as the difference in mean change (insulin minus saline) with a 95% confidence interval.
Time frame: baseline and day 21 post-intervention
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Nov 2026; primary completion for Nov 2027, 12 months later.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Insulin, Regular, Human